Group One Trading
RLMD icon

Group One Trading’s Relmada Therapeutics RLMD Stock Holding History

Group One Trading’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,350
Closed -$100K – 8352
2026
Q1 		$99.9K Buy
+14,350
New +$67.9K ﹤0.01% 4726
2025
Q3 		– Sell
-26,301
Closed -$25.2K – 9035
2025
Q2 		$15.8K Sell
26,301
-2,340
-8% -$1.2K ﹤0.01% 6426
2025
Q1 		$7.73K Sell
28,641
-73,446
-72% -$24.3K ﹤0.01% 6418
2024
Q4 		$53.1K Buy
102,087
+3,142
+3% +$7.66K ﹤0.01% 5010
2024
Q3 		$321K Sell
98,945
-49,982
-34% -$162K ﹤0.01% 3208
2024
Q2 		$447K Sell
148,927
-35,411
-19% -$128K ﹤0.01% 2670
2024
Q1 		$857K Buy
184,338
+25,911
+16% +$125K ﹤0.01% 2226
2023
Q4 		$656K Sell
158,427
-2,076
-1% -$6.15K ﹤0.01% 2843
2023
Q3 		$482K Buy
160,503
+23,948
+18% +$71.1K ﹤0.01% 2949
2023
Q2 		$336K Buy
136,555
+92,861
+213% +$257K ﹤0.01% 3424
2023
Q1 		$98.7K Sell
43,694
-99,841
-70% -$344K ﹤0.01% 4312
2022
Q4 		$501K Buy
+143,535
New +$1.26M ﹤0.01% 3039
2022
Q3 		– Sell
-3,354
Closed -$92.9K – 8128
2022
Q2 		$64K Buy
+3,354
New +$73.2K ﹤0.01% 5360
2021
Q4 		– Sell
-2,035
Closed -$45.3K – 8753
2021
Q3 		$53K Sell
2,035
-5,185
-72% -$139K ﹤0.01% 6501
2021
Q2 		$231K Buy
7,220
+1,000
+16% +$34.7K ﹤0.01% 5083
2021
Q1 		$219K Buy
+6,220
New +$218K ﹤0.01% 4939

Other funds holding RLMD

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Group One Trading's RLMD Position: Q2 2026 in Review

Group One Trading sold out of Relmada Therapeutics (RLMD) in Q2 2026, closing a stake of 14,350 shares — an estimated $100K sold.

Group One Trading first reported a position in RLMD in Q1 2021 and held it in 16 quarters. The position peaked at $857K in Q1 2024. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • Group One Trading reported no remaining Relmada Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 14,350 Relmada Therapeutics shares in Q2 2026, an estimated $100K.
  • Group One Trading first reported a position in Relmada Therapeutics in Q1 2021 and held it in 16 quarters.
  • Group One Trading's Relmada Therapeutics position peaked at $857K in Q1 2024.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.